<DOC>
	<DOCNO>NCT01460706</DOCNO>
	<brief_summary>The purpose study characterize tumour uptake somatostatin analog 68Ga-DOTATOC patient either primary recurrent malignant glioma . The investigator hypothesis primary recurrent malignant glioma overexpress SST2 receptor image 68Ga-DOTATOC PET/CT . The investigator also hypothesize tumor uptake 68Ga-DOTATOC correlate immunohistochemically determine SST2 receptor status tumor specimen .</brief_summary>
	<brief_title>Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<mesh_term>Edotreotide</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Age : 18 70 year old Language spoken : Finnish Swedish Performance status : Karnofsky score 70 better WHO performance status 2 well Supratentorial malignant glioma base MRI image Supratentorial recurrent glioma base MRI and/or [ 11C ] methionine PET image Patients must able understand meaning study sign appropriate Ethical Committee approve informed consent document presence designated staff Any medical psychiatric condition compromise subjectÂ´s ability participate study Any significant disease include liver renal disease Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Glioma</keyword>
	<keyword>68Ga-DOTATOC</keyword>
	<keyword>PET/CT</keyword>
	<keyword>Somatostatin receptor</keyword>
</DOC>